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INTRODUCTION: Neisseria gonorrhoeae (NG) is the Gram-negative diplococci responsible for gonorrhoea. As most of the NG clinical
isolates have developed resistance to at list one of the antibiotic drugs prescribed to this sexually transmitted disease, including tetracyclines
(T) and macrolides (M), the microorganism susceptibility pattern should determine the choice of therapy1,2. Several studies have shown that
MALDI-ToF significantly accelerates the resistance phenotyping compared to the commonly used routine antibiotic susceptibility tests 3.
1. STD Facts - Gonorrhea. https://www.cdc.gov/std/gonorrhea/stdfact-gonorrhea.htm (2019).
2. 82 - Neisseria gonorrhoeae. in Molecular Medical Microbiology (Second Edition) (eds. Tang, Y.-W., Sussman, M., Liu, D., Poxton, I. & Schwartzman, J.) 1471–1485 (Academic Press, 2015). doi:10.1016/B978-0-12-397169-2.00082-2.
3. Burckhardt, I. & Zimmermann, S. Susceptibility Testing of Bacteria Using Maldi-Tof Mass Spectrometry. Front. Microbiol. 9, (2018).
4. Direct Bacterial Profiling by Matrix-Assisted Laser Desorption−Ionization Time-of-Flight Mass Spectrometry for Identification of Pathogenic Neisseria. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607569/.
CLINICAL IMPLEMENTATION OF THE PROPOSED WORK: The proof of concept is expected to: – Improve the gonococcal infection
treatment by the generation of a more efficient protocol applicable to routine laboratory (decrease in health care expenditure). – Check the
MALDI-ToF technique efficiency against phenotyping RB resistances. – Generate a suitable dataset for the development of further molecular
and epidemiological studies.
1 OBJECTIVES
To develop a shorter and clinically
applicable protocol that allows resistance
phenotyping to M and T in NG clinical
isolates using MALDI-ToF technology.
To show that the Mass Spectrometry (MS)
data which will be obtained contain strong
signal for the clustering of M and T
antibiotics resistant (R) and susceptible (S)
NG clinical isolates.
To applicate supervised learning to extract
and verify the important features leading to
the clustering.
(Future perspective) To reprocess the false
negatives by Tandem Mass Spectrometry
(MS/MS) providing an adequate dataset for
the development of further studies.
MATERIALS AND METHODS2
The study samples will be pre-processed
and classified into two experimental
groups, as illustrated in the following
diagram (See diagram 1).
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3 MATERIALS AND METHODS
D1 and D2 will be used as learning data for
the detection of T and M resistance
respectively. Spectrums proceeding from
new clinical isolates will be pre-processed
as the ones belonging to datasets 1-2 and all
together will be used for the building of a
Random Forest model for testing, serving
as training data.
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4 EXPECTED RESULTS
BIOMARKERS DETECTION
Ribosome-based resistance (RBS)
biomarkers will be detected within 12.000
m/z range 4. Signature peaks correlated with
little ribosomal subunit proteins will be
emplaced near 9.500 m/z (D1).
Variants of this peaks may be seen in
the same m/z range in D2.
Between 35.000 – 37.000 m/z, porin B
defects could be measured. The differential
peak might be seen in both datasets. We
can expect the peaks related to RND
pumps near 40.000 m/z (D2). Other pumps
such as acrEF-tolC, mexCD-oprJ, and
mtrCDE can also be emplaced there.
RANDOM FOREST MODEL
Random Forest should perform a binary
discriminant analysis in which samples will
be classified into: M and T (R)- isolates, M
and T (S)-isolates, M (S) and T (R) isolates
and vice versa. True positive results should
be treated with cefixime and ceftriaxone,
whereas true negative results with
azithromycin and T. False positive results
will not be detectable, whereas false
negative results should be processed by
MS/MS.
The spectrometric analysis will be carried
out via MALDI-Tof system (Reflectron
mode). The generated data will be
imported in two different datasets (T = D1
and M = D2) using the “Maldiquant”
package. The R and S isolates spectra for
the studied antibiotics will be aligned
between each other. An intensity-based
feature matrix for the signature detected
peaks will be performed.
For matching the peaks of interest with
their respective proteins, their m/z value
will be compared against the
SwissProt/TrEMBL database by manual
search.
Diagram 1 – Schematized proposed workflow. Self-source, based on Gibb, et al. work.
NG- Neisseria gonorrhoeae./ TS or TR- Tetracycline susceptible or resistant./ MS or MR – Macrolide susceptible or resistant./ Mass Sp.- Mass spectrum.
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